Healios K.K. (TYO:4593)
Japan · Delayed Price · Currency is JPY 378.00
+11.00 (3.00%)
At close: Mar 27, 2026
Healios K.K. Market Cap
Healios K.K. has a market cap or net worth of 51.03 billion as of March 27, 2026. Its market cap has increased by 67.36% in one year.
Market Cap
51.03B
Enterprise Value
47.97B
Revenue
104.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
378.00
Market Cap Chart
Since June 16, 2015, Healios K.K.'s market cap has decreased from 67.08B to 51.03B, a decrease of -23.92%. That is a compound annual growth rate of -2.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 51.03B | 61.32% |
| Dec 30, 2025 | 31.63B | 98.29% |
| Dec 30, 2024 | 15.95B | 29.70% |
| Dec 29, 2023 | 12.30B | -25.62% |
| Dec 30, 2022 | 16.54B | -76.63% |
| Dec 30, 2021 | 70.75B | -30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SanBio Company | 143.27B |
| Takara Bio | 138.24B |
| Nxera Pharma | 78.73B |
| Oncolys BioPharma | 66.86B |
| Cuorips | 58.10B |
| Japan Tissue Engineering | 30.42B |
| Stella Pharma | 26.48B |
| AnGes | 22.95B |